{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:26:49Z","timestamp":1791077209236,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.biopha.2005.06.011","type":"journal-article","created":{"date-parts":[[2005,10,24]],"date-time":"2005-10-24T14:12:38Z","timestamp":1130163158000},"page":"545-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Antileishmanial and\u00a0trypanocidal activities of\u00a0new miltefosine liposomal formulations"],"prefix":"10.1016","volume":"59","author":[{"given":"A.","family":"Papagiannaros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bories","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Demetzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2005.06.011_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","article-title":"Chemotherapy of leishmaniasis","volume":"8","author":"Croft","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2005.06.011_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans Roy Soc Trop Med Hygiene"},{"key":"10.1016\/j.biopha.2005.06.011_bib3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis and treatment and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2005.06.011_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.drup.2004.07.002","article-title":"Leishmaniasis: drugs in the clinic, resistance and new developments","volume":"7","author":"Ouellette","year":"2004","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.biopha.2005.06.011_bib5","series-title":"Antitumor ether lipids, biological and biochemical lipids","first-page":"125","author":"Bittman","year":"1999"},{"key":"10.1016\/j.biopha.2005.06.011_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0306-3623(98)00081-0","article-title":"Cytotoxic ether lipid analogues","volume":"31","author":"Berkovic","year":"1998","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.biopha.2005.06.011_bib7","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.45.6.1872-1875.2001","article-title":"Activities of hexadecylphosphocholine (miltefosine), ambisome and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice","volume":"45","author":"Escobar","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2005.06.011_bib8","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/AAC.46.11.3472-3477.2002","article-title":"Proinflammatory and cytotoxic effects of hexadecylphosphocholine (Mitelfosine) against drug resistant strains of Trypanosoma cruzi","volume":"46","author":"Saraiva","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2005.06.011_bib9","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishsmaniasis","volume":"352","author":"Sundar","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2005.06.011_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0001-706X(96)00628-6","article-title":"Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies","volume":"64","author":"Konstantinov","year":"1997","journal-title":"Acta Trop."},{"key":"10.1016\/j.biopha.2005.06.011_bib11","first-page":"1","article-title":"Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania","volume":"111","author":"Lux","year":"2000","journal-title":"Mol. Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2005.06.011_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bmmb.1994.1050","article-title":"Mannose coated liposomal hamycin in the treatment of experimental leishmaniasis in Hamsters","volume":"53","author":"Benerjee","year":"1994","journal-title":"Biochem. Med. Metab. Biol."},{"key":"10.1016\/j.biopha.2005.06.011_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijpharm.2004.03.025","article-title":"Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough","volume":"278","author":"Morilla","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2005.06.011_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0035-9203(99)90036-6","article-title":"Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis","volume":"93","author":"Bodhe","year":"1999","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.biopha.2005.06.011_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jps.1023","article-title":"Trends and developments in liposome drug delivery systems","volume":"90","author":"Lian","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2005.06.011_bib16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(97)00135-X","article-title":"Liposomes in drug delivery: progress and limitations","volume":"154","author":"Sharma","year":"1997","journal-title":"Int. Pharm."},{"key":"10.1016\/j.biopha.2005.06.011_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0005-2736(96)00090-9","article-title":"Preparation and properties of sterically stabilized hexadecylphosphocholine (miltefosine) liposomes and influence of this on macrophage activation","volume":"1283","author":"Zeisig","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2005.06.011_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0005-2736(97)00043-6","article-title":"Combination. of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity","volume":"1327","author":"Perkins","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.biopha.2005.06.011_bib19","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.75.9.4194","article-title":"Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation","volume":"75","author":"Szoka","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2005.06.011_bib20","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1073\/pnas.83.8.2422","article-title":"Stabilization of lipid bilayer vesicles by sucrose during freezing","volume":"83","author":"Straus","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2005.06.011_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1211\/0022357044382","article-title":"Encapsulation of naturally occurring flavonoids into liposomes. Studies on their physicochemical properties and on their biological activity against human cancer cell lines","volume":"56","author":"Goniotaki","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2005.06.011_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02544028","article-title":"Separation and quantification of phospholipids in animal tissues Iatroscan TLC\/FID","volume":"26","author":"De Schrijver","year":"1991","journal-title":"Lipids"},{"key":"10.1016\/j.biopha.2005.06.011_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0005-2760(70)90046-9","article-title":"The detection of oxidation in liposome preparations","volume":"210","author":"Klein","year":"1970","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2005.06.011_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0166-6851(02)00283-9","article-title":"Antiprotozoal activities of phospholipid analogues","volume":"126","author":"Croft","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2005.06.011_bib25","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1128\/AAC.44.11.2954-2961.2000","article-title":"Contribution of dithiol ligands to the in vitro and in vivo trypanocidal activities of dithiaarsanes and study of ligand exchange in aqueous solution","volume":"44","author":"Loiseau","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2005.06.011_bib26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","article-title":"Trial of oral miltefosine for visceral leishmaniasis","volume":"352","author":"Sundar","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2005.06.011_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"Seifert","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.biopha.2005.06.011_bib28","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1128\/AAC.44.6.1739-1742.2000","article-title":"Antileishmanial activities of stearylamine bearing liposomes","volume":"44","author":"Dey","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.biopha.2005.06.011_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbamem.2004.01.010","article-title":"Hexadecylphosphocholine interactions with lipid monolayers","volume":"1661","author":"Rakotomanga","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2005.06.011_bib30","first-page":"49965","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocate from Leishmania involved in drug resistance","volume":"278","author":"Perez-Victoria","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2005.06.011_bib31","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/AAC.49.7.2677-2686.2005","article-title":"Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequence for drug-membrane interactions","volume":"49","author":"Rakotomanga","year":"2005","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.biopha.2005.06.011_bib32","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/AAC.32.7.966","article-title":"In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomes","volume":"32","author":"Tachibana","year":"1988","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332205001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332205001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:36:00Z","timestamp":1760092560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332205001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0753332205001915"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2005.06.011","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antileishmanial and\u00a0trypanocidal activities of\u00a0new miltefosine liposomal formulations","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2005.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}